Brain Protein SORLA Blocks Alzheimer's Tau Damage in Mice

A natural protein in your brain might be one of your best defenses against Alzheimer's disease, and scientists just figured out how it works.

Researchers at Sanford Burnham Prebys discovered that a protein called SORLA can protect the brain from tau tangles, the twisted clumps that damage neurons and cause dementia. The findings, published in Science Advances on July 17, 2026, reveal a promising path toward future treatments.

Under normal conditions, tau proteins help neurons maintain their shape and function. But in Alzheimer's and related diseases, tau twists into toxic tangles that destroy the brain circuits they're supposed to protect.

The research team tested whether SORLA could interfere with this damage. They bred mice with elevated human SORLA levels and compared them to mice that developed tau tangles and brain decline.

The results were striking. Mice with extra SORLA had significantly less tau buildup, reduced brain shrinkage, and healthier connections between neurons. The protein blocked the process where tau becomes hyperphosphorylated and prevented malformed tau from recruiting more proteins into larger, more damaging clumps.

"When you upregulate SORLA, you can suppress the negative effects found in tauopathies," said Dr. Huijie Huang, lead author of the study. "We found there was less brain atrophy and less tau accumulation, which was very exciting to see."

The team also studied mice engineered without SORLA. These animals experienced the opposite effect: tau damage accelerated and brain decline worsened. This confirmed that SORLA plays a crucial protective role naturally.

Using advanced sequencing techniques, researchers discovered SORLA's protection extends beyond neurons. The protein also reduced harmful activity in glial cells, which support brain health and respond to damage.

The Bright Side

The discovery gets even more promising. The team identified a specific receptor that becomes overactive when SORLA is absent. Drugs already exist that target this receptor class, meaning scientists might be able to repurpose existing medications to treat tau-related dementias.

Dr. Timothy Huang, senior author of the study, explained that his lab has spent nearly two decades studying how SORLA suppresses amyloid-beta, another hallmark of Alzheimer's. Now they've shown it works against tau tangles too, addressing both sides of the disease.

Some people carry genetic mutations that disrupt their ability to produce SORLA, potentially making them more vulnerable to dementia. Understanding this connection could help identify at-risk individuals earlier and develop personalized prevention strategies.

The research team plans to study how different brain cell types respond to SORLA changes, including experiments with human neurons grafted into mouse brains. This could reveal even more detailed mechanisms and treatment targets.

For the millions of families touched by Alzheimer's and related dementias, this research offers something genuinely hopeful: a naturally occurring protein that protects the brain, and potential pathways to harness that protection therapeutically.